Mitotane is used to treat cancer of the adrenal glands (adrenocortical carcinoma) that cannot be removed by surgery. This medicine acts on a part of the body called the adrenal cortex. Mitotane reduces the amount of steroids (cortisone-like hormones) that are produced by the adrenal cortex. It is grouped under the following drug class(es): Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lysodren, Chloditan, Chlodithane and Opeprim. Its PubChem CID is 4211.
Mitotane
| CAS No | 53-19-0 |
|---|---|
| Molecular Formula | C14H10Cl4 |
| Molecular Weight | 320.00 g/mol |
| Synonyms | 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitotane is used to treat cancer of the adrenal glands (adrenocortical carcinoma) that cannot be removed by surgery. This medicine acts on a part of the body called the adrenal cortex.
The listed CAS number is 53-19-0.
The listed molecular formula is C14H10Cl4.
The listed molecular weight is 320.00 g/mol.
1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene.
The source lists Lysodren, Chloditan, Chlodithane and Opeprim.